Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Ana Gleisner

Concepts (293)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pancreatic Neoplasms
21
2023
731
3.750
 Why?
Sentinel Lymph Node
8
2022
37
2.940
 Why?
Adenocarcinoma
20
2023
795
2.720
 Why?
Liver Neoplasms
21
2024
506
2.700
 Why?
Melanoma
11
2022
619
2.610
 Why?
Laparoscopy
8
2021
398
2.540
 Why?
Skin Neoplasms
11
2022
756
2.440
 Why?
Pancreaticoduodenectomy
10
2021
133
2.310
 Why?
Carcinoma, Hepatocellular
9
2024
211
2.010
 Why?
Lymph Node Excision
10
2023
139
1.960
 Why?
Pancreatectomy
6
2023
171
1.850
 Why?
Sentinel Lymph Node Biopsy
11
2023
99
1.610
 Why?
Hepatectomy
17
2024
119
1.530
 Why?
Minimally Invasive Surgical Procedures
5
2020
154
1.340
 Why?
Postoperative Complications
11
2023
2128
1.230
 Why?
Liver Transplantation
10
2023
707
1.020
 Why?
Lymph Nodes
7
2023
419
0.970
 Why?
Esophagectomy
4
2021
111
0.970
 Why?
Retrospective Studies
51
2024
12542
0.920
 Why?
Robotic Surgical Procedures
3
2019
85
0.910
 Why?
Esophageal Neoplasms
7
2023
273
0.910
 Why?
Conversion to Open Surgery
2
2020
14
0.860
 Why?
Nomograms
2
2022
41
0.850
 Why?
Carcinoma, Pancreatic Ductal
5
2023
211
0.840
 Why?
Breast Neoplasms
4
2023
1862
0.800
 Why?
Survival Rate
22
2023
1644
0.790
 Why?
Rectal Neoplasms
5
2023
121
0.770
 Why?
Lymphatic Metastasis
10
2023
275
0.770
 Why?
Prognosis
24
2024
3328
0.730
 Why?
Aged
45
2023
19061
0.680
 Why?
Quality of Life
2
2019
2353
0.630
 Why?
Middle Aged
54
2023
26719
0.620
 Why?
Neoplasm Recurrence, Local
10
2023
858
0.610
 Why?
Head and Neck Neoplasms
6
2019
427
0.600
 Why?
Humans
92
2024
114623
0.600
 Why?
Colorectal Neoplasms
7
2017
615
0.560
 Why?
Neoadjuvant Therapy
11
2023
304
0.550
 Why?
Neoplasm Staging
10
2023
1167
0.530
 Why?
Female
65
2023
59466
0.520
 Why?
Colectomy
3
2013
86
0.510
 Why?
Liver Failure
3
2009
75
0.480
 Why?
Male
61
2023
55554
0.480
 Why?
Colonic Neoplasms
2
2013
215
0.440
 Why?
Risk Assessment
5
2019
2967
0.440
 Why?
Axilla
3
2023
39
0.430
 Why?
Decision Making
1
2019
782
0.420
 Why?
Follow-Up Studies
13
2021
4411
0.420
 Why?
Treatment Outcome
19
2023
9084
0.400
 Why?
Databases, Factual
6
2019
1124
0.350
 Why?
Neuroendocrine Tumors
2
2023
85
0.330
 Why?
Benchmarking
2
2021
161
0.330
 Why?
Aged, 80 and over
15
2021
6344
0.320
 Why?
Single Photon Emission Computed Tomography Computed Tomography
2
2019
10
0.320
 Why?
Metastasectomy
2
2023
13
0.320
 Why?
Peritoneal Neoplasms
2
2020
54
0.310
 Why?
Margins of Excision
4
2023
29
0.300
 Why?
Propensity Score
2
2019
224
0.300
 Why?
Length of Stay
4
2019
962
0.290
 Why?
Mastectomy, Segmental
2
2017
76
0.290
 Why?
Disease-Free Survival
8
2024
620
0.280
 Why?
Catheter Ablation
2
2008
288
0.270
 Why?
Hyperglycemia
2
2020
291
0.250
 Why?
Adult
28
2022
30528
0.250
 Why?
Cohort Studies
10
2023
4894
0.240
 Why?
Abdomen, Acute
1
2004
18
0.230
 Why?
Liver Cirrhosis
3
2023
227
0.230
 Why?
Bacterial Infections
3
2006
218
0.230
 Why?
Lymphopenia
1
2024
49
0.220
 Why?
United States
14
2023
12176
0.220
 Why?
Lung Neoplasms
3
2023
2177
0.210
 Why?
SEER Program
2
2014
196
0.210
 Why?
Multilocus Sequence Typing
1
2022
12
0.210
 Why?
Survival Analysis
6
2017
1211
0.210
 Why?
Mastectomy
1
2023
99
0.210
 Why?
Lymphoscintigraphy
2
2019
9
0.210
 Why?
Surgical Oncology
1
2022
18
0.210
 Why?
Pelvic Exenteration
2
2019
11
0.200
 Why?
Klatskin Tumor
1
2021
4
0.200
 Why?
Anesthetics, Inhalation
1
2021
14
0.190
 Why?
Cytoreduction Surgical Procedures
2
2020
38
0.190
 Why?
Prospective Studies
8
2022
6217
0.190
 Why?
Bile Duct Neoplasms
1
2021
56
0.190
 Why?
Propofol
1
2021
43
0.180
 Why?
Chemoradiotherapy
4
2023
188
0.180
 Why?
Hyperthermia, Induced
2
2020
65
0.180
 Why?
Organ Preservation
4
2023
64
0.180
 Why?
Odds Ratio
3
2019
953
0.180
 Why?
Registries
2
2021
1767
0.170
 Why?
Combined Modality Therapy
5
2019
1121
0.170
 Why?
Reoperation
3
2017
514
0.170
 Why?
Chemotherapy, Adjuvant
5
2023
332
0.170
 Why?
Anesthesia
1
2021
117
0.170
 Why?
Scalp
1
2019
29
0.170
 Why?
Regression Analysis
2
2019
944
0.160
 Why?
Pancreatic Diseases
1
2019
64
0.160
 Why?
Skin Pigmentation
1
2019
39
0.160
 Why?
Neoplasms
2
2022
2097
0.150
 Why?
Population Surveillance
1
2021
392
0.150
 Why?
Tumor Burden
3
2023
259
0.150
 Why?
Appendiceal Neoplasms
1
2017
14
0.150
 Why?
Patient Reported Outcome Measures
1
2019
250
0.140
 Why?
Patient Compliance
1
2021
524
0.140
 Why?
Common Bile Duct Neoplasms
1
2017
24
0.140
 Why?
Ampulla of Vater
1
2017
30
0.140
 Why?
Waiting Lists
2
2009
211
0.140
 Why?
Disease Management
1
2021
560
0.140
 Why?
Gastric Outlet Obstruction
1
2017
7
0.140
 Why?
Pylorus
1
2017
13
0.140
 Why?
Carcinoma, Ductal, Breast
1
2017
76
0.140
 Why?
Radiotherapy, Intensity-Modulated
1
2018
124
0.140
 Why?
Nutritional Status
1
2019
287
0.140
 Why?
Hospitals, High-Volume
1
2016
39
0.140
 Why?
Cancer Care Facilities
1
2016
29
0.140
 Why?
Genital Neoplasms, Female
1
2017
70
0.130
 Why?
Hospitals
1
2021
581
0.130
 Why?
Cannabis
1
2023
384
0.130
 Why?
Neuromuscular Agents
1
2017
30
0.130
 Why?
Time Factors
4
2021
6112
0.130
 Why?
Botulinum Toxins, Type A
1
2017
40
0.130
 Why?
Proportional Hazards Models
2
2022
1075
0.130
 Why?
Tomography, X-Ray Computed
2
2016
2279
0.130
 Why?
Tomography, Emission-Computed, Single-Photon
1
2016
76
0.130
 Why?
Carcinoma, Non-Small-Cell Lung
1
2023
961
0.130
 Why?
Adenoma
1
2017
189
0.130
 Why?
Anti-Bacterial Agents
1
2004
1477
0.120
 Why?
Radiosurgery
1
2018
299
0.120
 Why?
Antineoplastic Agents
3
2021
1879
0.120
 Why?
Patient Readmission
1
2019
609
0.120
 Why?
Kaplan-Meier Estimate
2
2013
811
0.110
 Why?
Delivery of Health Care
1
2021
833
0.110
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2022
1355
0.110
 Why?
Morbidity
4
2021
280
0.110
 Why?
Trauma Centers
2
2014
362
0.110
 Why?
Unnecessary Procedures
1
2014
44
0.110
 Why?
Abdomen
1
2013
99
0.110
 Why?
Clinical Competence
1
2019
893
0.100
 Why?
Radiation Dosage
1
2014
132
0.100
 Why?
Renal Insufficiency
1
2013
137
0.100
 Why?
Risk Factors
5
2019
8628
0.100
 Why?
Asia
2
2021
53
0.090
 Why?
Triage
1
2012
199
0.090
 Why?
Age Factors
4
2022
2894
0.090
 Why?
Carcinoma, Renal Cell
1
2012
168
0.090
 Why?
Practice Guidelines as Topic
1
2017
1394
0.090
 Why?
Europe
2
2021
334
0.080
 Why?
Kidney Transplantation
2
2013
541
0.080
 Why?
Graft Survival
2
2009
446
0.080
 Why?
Practice Patterns, Physicians'
1
2017
1177
0.080
 Why?
Organ Preservation Solutions
2
2006
39
0.080
 Why?
Brain Injuries
1
2014
461
0.080
 Why?
Young Adult
7
2022
10455
0.080
 Why?
Laparotomy
1
2008
103
0.080
 Why?
Kidney Neoplasms
1
2012
327
0.080
 Why?
Bile Ducts, Extrahepatic
1
2008
24
0.070
 Why?
Biliary Tract Surgical Procedures
1
2008
21
0.070
 Why?
Gallbladder Neoplasms
1
2007
11
0.070
 Why?
Neoplasm Invasiveness
3
2020
442
0.070
 Why?
Intraoperative Care
1
2007
34
0.070
 Why?
Anus Neoplasms
1
2007
24
0.070
 Why?
Cholangitis, Sclerosing
1
2008
66
0.070
 Why?
Electrocoagulation
1
2007
38
0.070
 Why?
Hospital Mortality
3
2019
776
0.070
 Why?
Congenital Hypothyroidism
1
1986
11
0.070
 Why?
Ultrasonography, Interventional
1
2007
123
0.070
 Why?
Fluorouracil
2
2022
152
0.070
 Why?
Adolescent
9
2022
17831
0.060
 Why?
Mycophenolic Acid
1
2006
77
0.060
 Why?
Pandemics
2
2023
1317
0.060
 Why?
Wounds and Injuries
1
2012
745
0.060
 Why?
Severity of Illness Index
2
2009
2537
0.060
 Why?
Radiotherapy, Adjuvant
2
2019
182
0.060
 Why?
Zygomycosis
1
2003
6
0.060
 Why?
Developmental Disabilities
1
1986
237
0.060
 Why?
alpha-Fetoproteins
1
2023
31
0.060
 Why?
Comorbidity
2
2022
1448
0.060
 Why?
Antibiotic Prophylaxis
1
2004
96
0.050
 Why?
Hepatocytes
1
2004
195
0.050
 Why?
Inflammation
2
2023
2477
0.050
 Why?
Appendicitis
1
2004
114
0.050
 Why?
Pneumonectomy
1
2023
125
0.050
 Why?
Biology
1
2023
78
0.050
 Why?
Capecitabine
1
2022
45
0.050
 Why?
Carcinoma, Squamous Cell
1
2007
577
0.050
 Why?
CA-19-9 Antigen
1
2022
14
0.050
 Why?
Anesthesia, Intravenous
1
2021
9
0.050
 Why?
Surgical Wound Infection
1
2004
248
0.050
 Why?
Liver
2
2006
1634
0.050
 Why?
Anesthetics, Intravenous
1
2021
27
0.050
 Why?
Models, Biological
1
2008
1620
0.050
 Why?
Esophagogastric Junction
1
2021
42
0.050
 Why?
Induction Chemotherapy
1
2021
56
0.050
 Why?
Medical Oncology
1
2022
229
0.050
 Why?
Case-Control Studies
1
2007
3003
0.040
 Why?
Thoracoscopy
1
2020
57
0.040
 Why?
Image-Guided Biopsy
1
2019
31
0.040
 Why?
Adenocarcinoma, Mucinous
1
2020
60
0.040
 Why?
Preoperative Period
1
2019
103
0.040
 Why?
Oxidative Stress
1
2004
1076
0.040
 Why?
Obesity
1
2010
2507
0.040
 Why?
Perioperative Period
1
2017
49
0.040
 Why?
Operative Time
1
2017
106
0.040
 Why?
ROC Curve
2
2009
442
0.040
 Why?
Carcinoma, Lobular
1
2017
44
0.040
 Why?
Occipital Bone
1
2017
17
0.030
 Why?
Parotid Gland
1
2017
24
0.030
 Why?
Gastric Emptying
1
2017
40
0.030
 Why?
Perioperative Care
1
2018
127
0.030
 Why?
Sex Factors
1
2022
1715
0.030
 Why?
Neck
1
2017
83
0.030
 Why?
Preoperative Care
2
2008
319
0.030
 Why?
Raffinose
2
2006
18
0.030
 Why?
Allopurinol
2
2006
53
0.030
 Why?
Consensus
1
2017
537
0.030
 Why?
Glucose
1
2020
896
0.030
 Why?
Quality Indicators, Health Care
1
2017
287
0.030
 Why?
Cross-Sectional Studies
2
2022
4405
0.030
 Why?
Glutathione
2
2006
293
0.030
 Why?
Adenosine
2
2006
203
0.030
 Why?
Drug Administration Schedule
1
2015
718
0.030
 Why?
Guideline Adherence
1
2017
490
0.030
 Why?
Child
6
2014
18404
0.030
 Why?
Glasgow Coma Scale
1
2014
151
0.030
 Why?
Child, Preschool
4
2014
9108
0.030
 Why?
Incidence
1
2019
2311
0.030
 Why?
Disease Progression
1
2020
2380
0.030
 Why?
Diagnostic Tests, Routine
1
2014
87
0.030
 Why?
Radiation Injuries
1
2014
128
0.030
 Why?
Vital Signs
1
2012
37
0.030
 Why?
New South Wales
1
2012
10
0.030
 Why?
Baltimore
1
2012
43
0.030
 Why?
Italy
1
2012
92
0.030
 Why?
Hospital Costs
1
2012
104
0.020
 Why?
Pharmaceutical Preparations
1
2013
165
0.020
 Why?
Albuminuria
1
1992
164
0.020
 Why?
Biological Therapy
1
2011
26
0.020
 Why?
Surveys and Questionnaires
1
2022
4620
0.020
 Why?
Chi-Square Distribution
1
2012
493
0.020
 Why?
Lung
1
2023
3558
0.020
 Why?
Injury Severity Score
1
2012
499
0.020
 Why?
Glomerular Filtration Rate
1
2013
604
0.020
 Why?
Infant, Newborn
2
2014
5043
0.020
 Why?
Multivariate Analysis
1
2013
1430
0.020
 Why?
Immunosuppressive Agents
1
2013
646
0.020
 Why?
Carcinoembryonic Antigen
1
2008
37
0.020
 Why?
Infant
3
2014
7959
0.020
 Why?
Antimetabolites, Antineoplastic
1
2008
81
0.020
 Why?
Sensitivity and Specificity
1
2012
1691
0.020
 Why?
Brazil
1
2008
89
0.020
 Why?
Fluorodeoxyglucose F18
1
2008
113
0.020
 Why?
Radiopharmaceuticals
1
2008
157
0.020
 Why?
Colorado
1
2017
4099
0.020
 Why?
Cholecystectomy
1
2007
45
0.020
 Why?
Retreatment
1
2007
67
0.020
 Why?
Positron-Emission Tomography
1
2008
259
0.020
 Why?
Incidental Findings
1
2007
70
0.020
 Why?
Neoplasm, Residual
1
2007
104
0.020
 Why?
Hepatitis B
1
2007
51
0.020
 Why?
Biopsy, Needle
1
2007
182
0.020
 Why?
Tablets, Enteric-Coated
1
2006
4
0.020
 Why?
Histidine
1
2006
57
0.020
 Why?
Overweight
1
2010
471
0.020
 Why?
Radiography
1
2008
812
0.020
 Why?
Psychological Tests
1
1986
120
0.020
 Why?
Insulin
2
2006
2076
0.020
 Why?
Graft Rejection
1
2009
513
0.020
 Why?
Tryptophan
1
2006
136
0.020
 Why?
Glutathione Disulfide
1
2004
26
0.010
 Why?
Hepatitis C
1
2007
219
0.010
 Why?
Gastrointestinal Diseases
1
2006
182
0.010
 Why?
Sulfamethoxypyridazine
1
1983
1
0.010
 Why?
Trimethoprim
1
1983
6
0.010
 Why?
Liver Function Tests
1
2004
103
0.010
 Why?
Anti-Infective Agents, Urinary
1
1983
13
0.010
 Why?
Amphotericin B
1
2003
29
0.010
 Why?
Liver Diseases
1
2006
255
0.010
 Why?
Patient Selection
1
2007
641
0.010
 Why?
Antifungal Agents
1
2003
128
0.010
 Why?
Body Mass Index
1
2010
1956
0.010
 Why?
Cause of Death
1
2004
361
0.010
 Why?
Urinary Tract Infections
1
1983
134
0.010
 Why?
Immunocompromised Host
1
2003
195
0.010
 Why?
Reperfusion Injury
1
2004
255
0.010
 Why?
Cardiovascular Diseases
1
1992
1727
0.010
 Why?
Diabetes Mellitus, Type 1
1
1992
3244
0.010
 Why?
Cholesterol
1
1992
367
0.010
 Why?
Blood Pressure
1
1992
1538
0.000
 Why?
Sulfamethoxazole
1
1983
6
0.000
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
1983
39
0.000
 Why?
Escherichia coli Infections
1
1983
100
0.000
 Why?
Drug Combinations
1
1983
287
0.000
 Why?
Microbial Sensitivity Tests
1
1983
300
0.000
 Why?
Escherichia coli
1
1983
720
0.000
 Why?
Clinical Trials as Topic
1
1983
931
0.000
 Why?
Gleisner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (293) concept(s)
_
Co-Authors Expand Description
See all (31) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)